Samuel Bakhoum: Featured News

Samuel Bakhoum: Featured News

Share
Print
Share
Print
Human metastatic melanoma cells in a lymph node. ENPP1, a protein involved in immune evasion, is shown in green.
Taking the STING Out of Cancer: Discovery about How Cancer Cells Evade Immune Defenses Inspires New Treatment Approach
The research identifies a protein called ENPP1 as a potential drug target in the treatment of advanced cancers with chromosome instability.
Roundup
2018
Top 10 Stories of 2018, Cancer Research Edition
Take a look back at some of the year’s biggest news in cancer research.
Sam Bakhoum, MD, PhD, has been named a winner of the 2018 National Institutes of Health Director’s Early Independence Award,
Samuel Bakhoum Awarded 2018 NIH Early Independence Award
Sam Bakhoum, MD, PhD, Assistant Attending in the Department of Radiation Oncology at Memorial Sloan Kettering Cancer Center (MSK), has been named a winner of the 2018 National Institutes of Health Director’s Early Independence Award, which is provided by the NIH Common Fund’s High-Risk, High-Reward Research program. This award is given to exceptional scientists who have contributed significant work in biomedical research.
In the Lab
Different viewpoints of the STING pathway
Putting the STING in Immunotherapy: Research Focuses on Ways to Improve Cancer Treatments
Researchers are looking for ways to make cancer cells more visible to the immune system.
In the Lab
Illustration of cells with blue nuclei that have green DNA bits floating in the cytoplasm
Escape Artists: Cancer Cells Mimic Immune Cell Activity to Spread
Researchers have discovered that cancer cells may hijack an immune response to spread from a primary tumor to distant organs.
Memorial Sloan Kettering radiation oncologist Samuel Bakhoum
At Work: Radiation Oncologist and Breast Cancer Specialist Samuel Bakhoum
Samuel Bakhoum is a physician-scientist who studies chromosomal instability and its role in how cancer grow and spreads.